Department of Diagnostic and Technology, Medical Genetics and Neurogenetics Unit, Fondazione IRCCS Istituto Neurologico "C.Besta", Milan, Italy.
Department of Cell and Molecular Biology and Microbiology, Faculty of Science and Technology, University of Isfahan, Isfahan, Islamic Republic of Iran.
Parkinsonism Relat Disord. 2022 Apr;97:52-56. doi: 10.1016/j.parkreldis.2022.03.007. Epub 2022 Mar 16.
The genetic basis of autosomal-recessive dystonia remains poorly understood. Our objective was to report identification of additional individuals with variants in AOPEP, a recently described gene for recessively inherited dystonic disorders (OMIM:619565).
Ongoing analysis on a high-throughput genetic platform and international case-recruitment efforts were undertaken.
Novel biallelic, likely pathogenic loss-of-function alleles were identified in two pedigrees of different ethnic background. Two members of a consanguineous Iranian family shared a homozygous c.1917-1G>A essential splice-site variant and featured presentations of adolescence-onset generalized dystonia. An individual of Chinese descent, homozygous for the nonsense variant c.1909G>T (p.Glu637*), displayed childhood-onset generalized dystonia combined with later-manifesting parkinsonism. One additional Iranian patient with adolescence-onset generalized dystonia carried an ultrarare, likely protein-damaging homozygous missense variant (c.1201C>T [p.Arg401Trp]).
These findings support the implication of AOPEP in recessive forms of generalized dystonia and dystonia-parkinsonism. Biallelic AOPEP variants represent a worldwide cause of dystonic movement-disorder phenotypes and should be considered in dystonia molecular testing approaches.
常染色体隐性遗传型肌张力障碍的遗传基础仍知之甚少。我们的目的是报告在 AOPEP 中发现更多的变异个体,该基因是最近描述的隐性遗传性肌张力障碍疾病的基因(OMIM:619565)。
在高通量遗传平台上进行正在进行的分析和国际病例招募工作。
在两个不同种族背景的家系中发现了新的双等位基因、可能具有致病性的失功能等位基因。一个伊朗近亲家庭的两名成员共享纯合 c.1917-1G>A 必需剪接位点变异,表现为青少年发病的全身性肌张力障碍。一个具有中国血统的个体,纯合子的无义变异 c.1909G>T(p.Glu637*),表现为儿童发病的全身性肌张力障碍伴随后出现的帕金森病。另一位伊朗患者在青少年发病的全身性肌张力障碍中携带一种罕见的、可能导致蛋白损伤的纯合子错义变异(c.1201C>T [p.Arg401Trp])。
这些发现支持 AOPEP 在隐性全身性肌张力障碍和肌张力障碍-帕金森病中的作用。双等位基因 AOPEP 变异是全球性导致肌张力障碍运动障碍表型的原因,应在肌张力障碍分子检测方法中考虑。